On March 26, 2026, a bipartisan group of U.S. lawmakers introduced H.R. 8094, titled the “AI Foundation Model Transparency Act of 2026” (“AI FMTA”). At its core, the AI FMTA would require developers of certain large AI Models, like ChatGPT or Claude, to publicly disclose key information about how the models are trained, what the […]
Artificial Intelligence (AI)
Key AI, Cybersecurity, and Privacy Takeaways from the NAIC 2026 Spring Meeting
From March 22–25, the National Association of Insurance Commissioners (“NAIC”) held its 2026 Spring National Meeting in San Diego, California. During the meeting, the Innovation, Cybersecurity, and Technology Committee, along with its working groups on Third-Party Data and Models, Big Data and Artificial Intelligence, and Cybersecurity, addressed key developments regarding oversight of third-party data and […]
California Jumps into AI Procurement with State Governing Principles in an Executive Order
On March 30, 2026, California Governor Gavin Newsom signed Executive Order N-5-26 (the “Order”), aimed at governing the responsible procurement and deployment of Generative Artificial Intelligence (“GenAI”) across California’s state government. The Order builds on the foundation laid by Executive Order N-12-23, issued in September 2023, by directing a series of actions across multiple state […]
The Trump Administration’s AI Framework: Key Federal Policy Priorities and Legislative Recommendations
On March 20, 2026, the Trump Administration released its National Policy Framework for Artificial Intelligence (“AI Framework”), a legislative recommendation document intended to guide Congress in establishing a unified federal approach to artificial intelligence (“AI”) governance. The White House’s new AI Framework follows closely behind Senator Marsha Blackburn’s March 18, 2026, legislative discussion draft (“AI […]
EU Privacy Regulators Weigh in on the Proposed EU Biotech Act: Key Takeaways for Life Sciences Companies
On March 10, 2026, the European Data Protection Board (EDPB) and the European Data Protection Supervisor (EDPS) issued a joint opinion on the European Commission’s proposed EU Biotech Act – a forthcoming legislative framework expected to materially affect how clinical trials are designed, conducted, and governed in the EU. The proposal, introduced in December 2025, […]